MacroGenics, Inc.
MGNX
$1.31
-$0.06-4.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -31.83% | -82.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -31.83% | -82.52% | |||
| Cost of Revenue | -80.89% | 4.64% | |||
| Gross Profit | 118.82% | -136.65% | |||
| SG&A Expenses | -61.46% | 97.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.68% | 27.73% | |||
| Operating Income | 19.33% | -197.50% | |||
| Income Before Tax | -183.46% | -125.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -166.10% | -127.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -166.10% | -127.39% | |||
| EBIT | 19.33% | -197.50% | |||
| EBITDA | 19.56% | -190.64% | |||
| EPS Basic | -165.35% | -127.37% | |||
| Normalized Basic EPS | 19.35% | -190.03% | |||
| EPS Diluted | -161.31% | -127.79% | |||
| Normalized Diluted EPS | 19.35% | -190.21% | |||
| Average Basic Shares Outstanding | 0.29% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.29% | -0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||